- Home
- MITQ vs HSCS Comparison
MITQ vs HSCS Comparison
Compare MITQ & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MITQ
- HSCS
- Stock Information
- Founded
- MITQ N/A
- HSCS 2007
- Country
- MITQ United States
- HSCS United States
- Employees
- MITQ N/A
- HSCS N/A
- Industry
- MITQ Telecommunications Equipment
- HSCS Medical Specialities
- Sector
- MITQ Telecommunications
- HSCS Health Care
- Exchange
- MITQ Nasdaq
- HSCS Nasdaq
- Market Cap
- MITQ 7.6M
- HSCS 8.7M
- IPO Year
- MITQ 2021
- HSCS 2022
- Fundamental
- Price
- MITQ $0.75
- HSCS $3.33
- Analyst Decision
- MITQ
- HSCS Strong Buy
- Analyst Count
- MITQ 0
- HSCS 2
- Target Price
- MITQ N/A
- HSCS $13.00
- AVG Volume (30 Days)
- MITQ 47.9K
- HSCS 80.2K
- Earning Date
- MITQ 09-25-2025
- HSCS 09-09-2025
- Dividend Yield
- MITQ N/A
- HSCS N/A
- EPS Growth
- MITQ N/A
- HSCS N/A
- EPS
- MITQ N/A
- HSCS N/A
- Revenue
- MITQ $18,613,000.00
- HSCS $4,350.00
- Revenue This Year
- MITQ N/A
- HSCS $13,968.97
- Revenue Next Year
- MITQ N/A
- HSCS $166.67
- P/E Ratio
- MITQ N/A
- HSCS N/A
- Revenue Growth
- MITQ N/A
- HSCS N/A
- 52 Week Low
- MITQ $0.50
- HSCS $2.36
- 52 Week High
- MITQ $1.55
- HSCS $6.47
- Technical
- Relative Strength Index (RSI)
- MITQ 54.72
- HSCS 43.80
- Support Level
- MITQ $0.73
- HSCS $3.24
- Resistance Level
- MITQ $0.78
- HSCS $3.59
- Average True Range (ATR)
- MITQ 0.04
- HSCS 0.23
- MACD
- MITQ 0.00
- HSCS -0.01
- Stochastic Oscillator
- MITQ 66.67
- HSCS 13.04
About MITQ Moving iMage Technologies Inc.
Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.